Recurrence-free survival. A–C, Kaplan–Meier estimates of recurrence‐free survival in global samples according to AF, EpCAM, and EpCAM/AF expression levels. D–F, Kaplan–Meier estimates of recurrence‐free survival in global sample according to AF, EpCAM, and EpCAM/AF expression levels including LN involvement.
No takes yet. Share an insight, caveat, or question.
Alcalá et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: